Gustave Roussy shared on LinkedIn:
“The essentials of ESMO 2026 deciphered by the experts at Gustave Roussy.
What results should be presented at the ESMO26 should be remembered?
What advances are likely to change practices in oncologie?
On Tuesday, November 10, 2026, from 5 p.m., Gustave Roussy experts will offer health professionals an evening of deciphering devoted to the main lessons of the ESMO – European Society for Medical Oncology Congress.
Pathology by pathology, Gustave Roussy’s specialists will review the studies and key results of this 2026 edition to analyse their clinical scope and put into perspective the advances to be remembered. Sarcomas, pediatric, genitourinary, digestive, cerebral, ENT, gynecological, mammary, cutaneous and thoracic tumors will be addressed. Time will also be devoted to supportive care, connected health and cancer drugs in early stages of development.
Strongly mobilized in the clinical recherche, Gustave Roussy teams actively contribute to the scientific advances presented at major international congresses. This Post-ESMO offers the opportunity to offer an expert, critical and directly useful reading of it for clinical practice.
Free and mandatory – registration.”
Other articles about Gustave Roussy on OncoDaily.